 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Axys Pharmaceuticals, Inc.
 |
Axys Pharmaceuticals, Inc. |
 |
 |
 |
NEWS FROM THE STANDARD |
 |
Headlines
Jun 18 2001 12:00 AM PDT
Celera Catches the Drug Bug
Jun 13 2001 04:27 PM PDT
PROFILE |
 |
This Axys wants to be the global power in drug discovery. Axys Pharmaceuticals tests innumerable small-molecule chemical compounds in the search for new drug leads. Targeting cancer, the firm takes these leads through all stages of development. In addition to operating its own oncology program, it partners with such drugmakers as Bayer, Aventis, and Merck to develop treatments for chronic conditions, including rheumatoid arthritis, osteoporosis, and inflammatory bowel disease. To help fund its drug development activities, Axys holds stakes in bioag company Akkadix (about 45%) and chemical library developer Discovery Partners International (about one-third). Genome mapper Celera Genomics plans to buy the company.
COMPETITION |
 |
Cell Therapeutics, Inc. (CTIC)
OSI Pharmaceuticals, Inc. (OSIP)
Telik, Inc. (TELK)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 7.00
1-Yr. Sales Growth: (81.7)%
Employees: 168
Revenue per employee: $41,666.67
KEY PEOPLE |
 |
Paul J. Hastings
CEO
CONTACT INFO |
 |
180 Kimball Way
South San Francisco, CA 94080
US
Phone: 650-829-1000
Fax: 650-829-1001
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |